CASE PRESENTATION
ON
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
By: Puskar kunwor To: Mr.Kumar swamy
M.Pharm ,1st year Asst.Professor
Dept. of clinical pharmacy
SAC college of pharmacy
Patient details:
• Age : 51 years
• Weight: 55kg
• Sex: male
• Unit- medicine- C, M.Ward
• Date of admission: 15/6/13
• Date of discharge: 21/6/13
Complaints on admission:
C/O Cough with expectoration since 2-3 years,whitish in colour,mucoid,ocassionally
blood tinged.
C/O Chest pain Rt.side
Medical history: H/O Loss of appetite, breathlesness, generalized weakness, fever
(evening rise in temp.)
Medication history: None
Family history : Nothing significant
Social History : Diet mixed, Appetite: good, Sleep undisturbed ,Chronic
smoker(since 10 years), Not an alcoholic
PHYSICAL EXAMINATION
General : BP: 100/70 mmhg, PR: 92bpm
CVS:S1,S2+,Nomermers
RS:diminishedbreathsounds+
CNS:NFND
• Mildpallor
SOAP ANALYSIS FOR COPD
Subjective evidence
• C/o Cough with expectoration since 2-3 years,
• colour: whitish
• mucoid,ocassionally blood tinged.
• C/o Chest pain Rt.side,non radiating.
Objective evidence:
X-ray left basal Crepts
LAB DATA
Eosinophil: 5%
Neutrophil: 77%
Assessment:- From subjective and objective evidences it is
diagnosed that patient is suffering from COPD predominantely
Emphysema
Goals:
• Patient Specific:
– To reduce symptoms.
• Disease Specific:
– To reduce the frequency and severity of exacerbation and
improve health status.
Assessment of current therapy
Drugs Dose Route Freq Days
1 2 3 4 5 6 7
T. Cefixime 200mg PO 1-0-1 + + + + + stop
T.Ranitidine 150mg PO 1-0-0 + + + + + + +
Syp.Brozedex 2TSP PO 1-1-1 + + + + + + +
Nebn.Salbutamol
+Ipratropium Br
100/20
micro g
Inhal 1-1-1 + + + + + + +
Budesonide 0.5mg Inhal 6th hrly + + + + + + +
T.Theophyllin+Eto
phylline
35/115
mg
PO 1-0-1 + + + + + + +
PROGRESS REPORT
DAY 2
Pt.is alert & conscious
PR:86bpm, BP:120/80 mmHg, Pallor +,diminished breath sound +
DAY 3
PR:84 bpm, BP:118/80 mmHg, diminished breath sound +
DAY 4
PR:78bpm, BP:110/74 mmHg, diminished breath sound +
DAY 5
PR:80 bpm, BP:114/70 mmHg, diminished breath sound +
DAY 6
PR:78bpm, BP:110/70 mmHg, decreased breath sound
DAY 7
PR:78 bpm,BP:110/75 mmHg, decreased breath sound
Discharge medication
T. Theophyllin+Etophylline 150 mg,1-0-1
Duolin respulse,1-0-1
Syp .Brozedex 2TSP,1-1-1
Clinical Pharmacist Intervention
Adverse drug reaction:
• Cefixime: nephrotoxicity,neutropenia,thrombocytopenia
• Salbutamol:- tremors, tachycardia, palpitatons, dry and irritated
nose and throat, muscle cramps, hypokalemia
• Ipratropium: chest pain,bronchospasm,palpitation,headache.
• Budesonide: oral infections, throat irritation, hoarseness,
headache, adrenal insufficiency.
• Theophylline & Etofylline : hypersensitivity,circulatory
failure,ventricular arrythmias,tachycardia,respiratory arrest.
Drug -Drug interactions:
Salbutamol + Theophylline – May result in possible cardiac
adverse effects.
Monitoring Parameters
Salbutamol:-
I. Monitor serum potassium levels.It may cause hypokalemia.
II. Notify pt.that tremor & tachycardia may occur.
III. If GI problem occur ,administer drug with food.
Theophylline: ECG,respiratory rate
Patient Counseling:
– Mainly smoking cessation should be advised
– Some breathing exercise should be taught
– Psychological support should be given along with health
education
– Should be advised to avoid dust and allergens
– Medication adherence should be explained since it is an long
term therapy
– Ipratropium Bromide: Instruct patient to report signs/symptoms of
eye pain, blurred vision, excessively dry nasal passages, or nose
bleeds.
– Theophylline: Advise patient to take drug on empty stomach
THANK YOU

biki CASE PRESENTATION on COPD, respiratory.pptx

  • 1.
    CASE PRESENTATION ON CHRONIC OBSTRUCTIVEPULMONARY DISEASE By: Puskar kunwor To: Mr.Kumar swamy M.Pharm ,1st year Asst.Professor Dept. of clinical pharmacy SAC college of pharmacy
  • 2.
    Patient details: • Age: 51 years • Weight: 55kg • Sex: male • Unit- medicine- C, M.Ward • Date of admission: 15/6/13 • Date of discharge: 21/6/13
  • 3.
    Complaints on admission: C/OCough with expectoration since 2-3 years,whitish in colour,mucoid,ocassionally blood tinged. C/O Chest pain Rt.side Medical history: H/O Loss of appetite, breathlesness, generalized weakness, fever (evening rise in temp.) Medication history: None Family history : Nothing significant Social History : Diet mixed, Appetite: good, Sleep undisturbed ,Chronic smoker(since 10 years), Not an alcoholic
  • 4.
    PHYSICAL EXAMINATION General :BP: 100/70 mmhg, PR: 92bpm CVS:S1,S2+,Nomermers RS:diminishedbreathsounds+ CNS:NFND • Mildpallor
  • 5.
    SOAP ANALYSIS FORCOPD Subjective evidence • C/o Cough with expectoration since 2-3 years, • colour: whitish • mucoid,ocassionally blood tinged. • C/o Chest pain Rt.side,non radiating. Objective evidence: X-ray left basal Crepts LAB DATA Eosinophil: 5% Neutrophil: 77% Assessment:- From subjective and objective evidences it is diagnosed that patient is suffering from COPD predominantely Emphysema
  • 6.
    Goals: • Patient Specific: –To reduce symptoms. • Disease Specific: – To reduce the frequency and severity of exacerbation and improve health status.
  • 7.
    Assessment of currenttherapy Drugs Dose Route Freq Days 1 2 3 4 5 6 7 T. Cefixime 200mg PO 1-0-1 + + + + + stop T.Ranitidine 150mg PO 1-0-0 + + + + + + + Syp.Brozedex 2TSP PO 1-1-1 + + + + + + + Nebn.Salbutamol +Ipratropium Br 100/20 micro g Inhal 1-1-1 + + + + + + + Budesonide 0.5mg Inhal 6th hrly + + + + + + + T.Theophyllin+Eto phylline 35/115 mg PO 1-0-1 + + + + + + +
  • 8.
    PROGRESS REPORT DAY 2 Pt.isalert & conscious PR:86bpm, BP:120/80 mmHg, Pallor +,diminished breath sound + DAY 3 PR:84 bpm, BP:118/80 mmHg, diminished breath sound + DAY 4 PR:78bpm, BP:110/74 mmHg, diminished breath sound + DAY 5 PR:80 bpm, BP:114/70 mmHg, diminished breath sound + DAY 6 PR:78bpm, BP:110/70 mmHg, decreased breath sound DAY 7 PR:78 bpm,BP:110/75 mmHg, decreased breath sound
  • 9.
    Discharge medication T. Theophyllin+Etophylline150 mg,1-0-1 Duolin respulse,1-0-1 Syp .Brozedex 2TSP,1-1-1
  • 10.
    Clinical Pharmacist Intervention Adversedrug reaction: • Cefixime: nephrotoxicity,neutropenia,thrombocytopenia • Salbutamol:- tremors, tachycardia, palpitatons, dry and irritated nose and throat, muscle cramps, hypokalemia • Ipratropium: chest pain,bronchospasm,palpitation,headache. • Budesonide: oral infections, throat irritation, hoarseness, headache, adrenal insufficiency. • Theophylline & Etofylline : hypersensitivity,circulatory failure,ventricular arrythmias,tachycardia,respiratory arrest. Drug -Drug interactions: Salbutamol + Theophylline – May result in possible cardiac adverse effects.
  • 11.
    Monitoring Parameters Salbutamol:- I. Monitorserum potassium levels.It may cause hypokalemia. II. Notify pt.that tremor & tachycardia may occur. III. If GI problem occur ,administer drug with food. Theophylline: ECG,respiratory rate
  • 12.
    Patient Counseling: – Mainlysmoking cessation should be advised – Some breathing exercise should be taught – Psychological support should be given along with health education – Should be advised to avoid dust and allergens – Medication adherence should be explained since it is an long term therapy – Ipratropium Bromide: Instruct patient to report signs/symptoms of eye pain, blurred vision, excessively dry nasal passages, or nose bleeds. – Theophylline: Advise patient to take drug on empty stomach
  • 13.